"Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia is specialized in diabetes and obesity. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : https://www.adocia.com/careers/adocia-careers/
Looking for a particular ADOCIA employee's phone or email?
The ADOCIA annual revenue was $6.4 million in 2026.
Gerard Soula is the Chairman of ADOCIA.
74 people are employed at ADOCIA.
ADOCIA is based in Lyon, Wallis and Futuna.
The NAICS codes for ADOCIA are [5417, 54, 541, 541713, 54171].
The SIC codes for ADOCIA are [873, 87].